Mitchell P - Search Results

1

KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.

Clarke K, Basser RL, Underhill C, Mitchell P, Bartlett J, Cher L, Findlay M, Dalley D, Pell M, Byrne M, Geldard H, Hill JS, Maher D, Fox RM, Green MD, Kaye AH. Clarke K, et al. Among authors: mitchell p. J Clin Oncol. 1999 Aug;17(8):2579-84. doi: 10.1200/JCO.1999.17.8.2579. J Clin Oncol. 1999. PMID: 10561325 Clinical Trial.

2

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

Nowak AK, Byrne MJ, Williamson R, Ryan G, Segal A, Fielding D, Mitchell P, Musk AW, Robinson BW. Nowak AK, et al. Among authors: mitchell p. Br J Cancer. 2002 Aug 27;87(5):491-6. doi: 10.1038/sj.bjc.6600505. Br J Cancer. 2002. PMID: 12189542 Free PMC article. Clinical Trial.

3

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.

Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators. Peters S, et al. Among authors: mitchell p. Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. Ann Oncol. 2022. PMID: 34562610 Free article. Clinical Trial.

4

Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy.

Clarke S, Goldstein D, Mitchell P, Michael M, Beale P, Friedlander M, Zalcberg J, White S. Clarke S, et al. Among authors: mitchell p. Clin Colorectal Cancer. 2007 Jul;6(8):578-82. doi: 10.3816/CCC.2007.n.025. Clin Colorectal Cancer. 2007. PMID: 17681104

5

Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.

Samuel LM, Harvey VJ, Mitchell PL, Thompson PI, Mak D, Melville P, Evans BD. Samuel LM, et al. Among authors: mitchell pl. Eur J Cancer. 1994;30A(14):2054-6. doi: 10.1016/0959-8049(94)00273-8. Eur J Cancer. 1994. PMID: 7857702 Clinical Trial.

6

Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count.

Michael M, Goldstein D, Clarke SJ, Milner AD, Beale P, Friedlander M, Mitchell P. Michael M, et al. Among authors: mitchell p. Clin Colorectal Cancer. 2006 Nov;6(4):297-304. doi: 10.3816/CCC.2006.n.048. Clin Colorectal Cancer. 2006. PMID: 17241514

7

Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.

Itchins M, Chia PL, Hayes SA, Howell VM, Gill AJ, Cooper WA, John T, Mitchell P, Millward M, Clarke SJ, Solomon B, Pavlakis N. Itchins M, et al. Among authors: mitchell p. Asia Pac J Clin Oncol. 2017 Aug;13 Suppl 3:3-13. doi: 10.1111/ajco.12754. Asia Pac J Clin Oncol. 2017. PMID: 28795492 Review.

8

Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.

Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Among authors: mitchell p. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.

9

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, Rischin D. Loi S, et al. Among authors: mitchell p. Br J Cancer. 2005 Feb 28;92(4):655-61. doi: 10.1038/sj.bjc.6602413. Br J Cancer. 2005. PMID: 15700033 Free PMC article. Clinical Trial.

10

Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.

Goldstein D, Mitchell P, Michael M, Beale P, Friedlander M, Zalcberg J, White S, Clarke S. Goldstein D, et al. Among authors: mitchell p. Br J Cancer. 2005 Mar 14;92(5):832-7. doi: 10.1038/sj.bjc.6602426. Br J Cancer. 2005. PMID: 15756253 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,419 results

Search Page

Filters